🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open, multiple-center clinical study of renal preser...
Status
Recruiting
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-06-10
Trial ID
NCT05912816
Treatments Being Tested
This is a prospective, open, single-center clinical study of anti-HER2-ADC ...
Status
Unknown
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-08-05
Trial ID
NCT05957757
Treatments Being Tested
To evaluate the efficacy and safety of vidicizumab combined with tirelizuma...
Status
Unknown
Location
WuhanHU
Start Date
2023-02-01
Trial ID
NCT05861635
Treatments Being Tested
This is a prospective, single arm, multicenter phase II study aimed at eval...
Status
Active Not Recruiting
Location
Central Hospital Affiliated to Shandong First Medical University
Start Date
2023-02-10
Trial ID
NCT05586061
Treatments Being Tested
Disitamab Vedotin combined therapy locally advanced or metastatic NSCLC Pat...
Status
Unknown
Location
SunYat-senU
Start Date
2023-05
Trial ID
NCT05847764
Treatments Being Tested
Neoadjuvant chemotherapy treatment can be used for specific UTUC patients, ...
Status
Recruiting
Location
The Second Hospital of Tianjin Medical University
Start Date
2022-12-30
Trial ID
NCT05837806
Treatments Being Tested
As an established therapeutic target, HER2 is widely used in a variety of t...
Status
Unknown
Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Start Date
2023-07-18
Trial ID
NCT05578287
Treatments Being Tested
At present, there is no anti-HER2 therapy recommended by guidelines for sec...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2023-05-09
Trial ID
NCT05982834
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of \*\*Dis...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-05-15
Trial ID
NCT06944496
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Disitam...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-01-01
Trial ID
NCT07315750
Treatments Being Tested